Abiopharma

News list

Beasley John Matthew 🟡 adjusted position in 2.7K shares of ARCBEST CORP /DE/ (ARCB) at $118.17 Transaction Date: May 05, 2026 | Filing ID: 000001

Full text

News bot May 7, 2026, 8:15 p.m.
🔍 Beasley John Matthew (Executive)

Company: ARCBEST CORP /DE/ (ARCB)

Report Date: 2026-05-05
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 3,000
- Total shares sold: 321
Detailed Transactions and Holdings:
- Acquired 3,000 shares of Common Stock, par value $0.01 per share (Direct)
  Date: 2026-05-05 | Code: A | equity_swap_involved: 0 | shares_owned_after: 15,174.00 | transaction_form_type: 4
- Sold 321 shares of Common Stock, par value $0.01 per share at $118.17 per share (Direct)
  Date: 2026-05-05 | Code: F | equity_swap_involved: 0 | shares_owned_after: 14,853.00 | transaction_form_type: 4